Sofie Pattyn presented this poster at PEGS – the Protein Engineering Summit – in May 2024, on behalf of Martijn Vlaming, Emmanuelle Sidot, Jezabel Lefevere, Christoph Schifflers, Ellen Boelen and Sofie Pattyn.
Learn about in vitro assays – including a neutrophil activation assay and Treg suppression assay—to screen immuno-oncology drug candidates.
Complete the form to view/download the poster.
Related Insights
TruCulture®: Whole blood collection and culture system for clinical studies
In Vitro Immunology and Immunogenicity Brochure
Early Unwanted Immunogenicity Risk Assessment of Biotherapeutics
Olink® Target platform
Offering scalable multiplexing while preserving sensitivity and specificity
Advancing oncology research
Comprehensive blood-based protein biomarker testing for enhanced drug discovery and clinical trials
TruCulture®: A whole blood collection and culture system for clinical immunology studies
